V

Virogin Biotech Ltd

52 employees

Virogin Biotech is an antineoplastic drug developer.

Basic info

Industry

biotechnology research

Sectors

innovation
Biotechnology
viruses
biotechnology
oncology
tumour immunology
r&d
Health Care
biochemistry
immunotherapy
immuno-oncology
clinical trials
cancer

Date founded

2015

Funding rounds raised

Total raised

$62M

from 9 investors over 9 rounds

V

Virogin Biotech Ltd raised $62M on September 28, 2020

Investors: 北京北大明德科技发展有限公司, Korea Investment Partners, China Merchants Capital and CDH Investments

V

Virogin Biotech Ltd raised undisclosed on June 7, 2020

Investors: Sangel Capital

V

Virogin Biotech Ltd raised $10M on December 7, 2018

Investors: Sinopharm Capital 国药资本

V

Virogin Biotech Ltd raised $5M on February 28, 2017

Investors: Sangel Capital

V

Virogin Biotech Ltd raised $7M on March 21, 2016

Investors: Sangel Capital

V

Virogin Biotech Ltd raised undisclosed on August 1, 2015

Investors: Shenzhen Capital Group Co., Ltd

FAQ